HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Portfolio Holders from Q3 2023 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Debt / NOTE 1.000% 8/1
Principal, excl. options Q1 2024: 18.8 B
Holdings value Q1 2024: $606 M
Value change Q1 2024: -$2 B
Grand Portfolio weight change Q1 2024: -0.004%
Number of holders: 67
Number of buys Q1 2024: 23
Number of sells Q1 2024: -35
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: -0.019%
CUSIP: 40637HAF6

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Principal	Value	Change	Price	Investors
2024 Q1	$18.8 B	$606 M	-$2 B	$0.97	67
2023 Q4	$18.9 B	$637 M	+$51.3 M	$0.93	69
2023 Q3	$15.7 B	$553 M	+$552 M	$0.94	61